FDA Inspection
Sagar Sardesai, M.D.Sagar Sardesai, M.D. – FDA Inspection, Feb 12, 2021
Record Details
This FDA Inspection record concerns Sagar Sardesai, M.D., with an inspection on February 12, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Sagar Sardesai, M.D.
- Inspection Date
- February 12, 2021
- Product Type
- Drugs
View Company Profile
ID · 61a004e4-9114-476a-9323-f75062c6d394
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1135594
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.64(b)Safety reports
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sagar Sardesai, M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| January 20, 2026 | NAI | Bioresearch Monitoring |
Other documents for Sagar Sardesai, M.D.
- FDA Inspection 1300484 - 2026-01-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.